Atherogenese: Wechselspiel zwischen Cholesterin, Inflammation und Koagulation

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Herz Kardiovaskuläre Erkrankungen

• Publication date

  2005-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00059-005-2658-9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Possible Protective Role for C-Reactive Protein in Atherogenesis: Complement Activation by Modified Lipoproteins Halts Before Detrimental Terminal Sequence

  2004cited by this paper
• C-reactive protein reassessed.

  2004cited by this paper
• High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit.

  2004cited by this paper
• The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes.

  2004cited by this paper
• Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host.

  2004cited by this paper
• Antibiotic trials for coronary heart disease.

  2004cited by this paper
• Enzymatic Modification of Low-Density Lipoprotein in the Arterial Wall: A New Role for Plasmin and Matrix Metalloproteinases in Atherogenesis

  2004cited by this paper
• Beyond cholesterol: the enigma of atherosclerosis revisited

  2004cited by this paper
• C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

  2004cited by this paper
• Effects of heparin-mediated extracorporeal low-density lipoprotein precipitation beyond lowering proatherogenic lipoproteins--reduction of circulating proinflammatory and procoagulatory markers.

  2004cited by this paper
• [Position paper on primary prevention of cardiovascular diseases. Current edition of 25 March 2003 by the governing body of the German Society of Cardiology-Heart- and Cardiovascular Research, revised by request of the governing body via the Prevention Project Group].

  2004cited by this paper
• Does aggressive statin therapy offer improved cholesterol-independent benefits compared to conventional statin treatment?

  2004cited by this paper
• Prothrombotic and antithrombotic pathways in acute coronary syndromes.

  2003cited by this paper
• P38 MAPK: critical molecule in thrombin-induced NF-κB-dependent leukocyte recruitment

  2003cited by this paper
• Hyperhomocysteinemia and its role in the development of atherosclerosis.

  2003cited by this paper
• Inhibitory Effects of Glycoprotein IIb/IIIa Antagonists and Aspirin on the Release of Soluble CD40 Ligand During Platelet Stimulation

  2003cited by this paper
• Fibrinogen und Atherothrombose: vulnerable Plaque oder vulnerabler Patient?

  2003cited by this paper
• Simvastatin Initiated Early After Heart Transplantation: 8-Year Prospective Experience

  2003cited by this paper
• Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy.

  2003cited by this paper
• Preprocedural Level of Soluble CD40L Is Predictive of Enhanced Inflammatory Response and Restenosis After Coronary Angioplasty

  2003cited by this paper
• Scientific and therapeutic advances in antiplatelet therapy

  2003cited by this paper
• Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction.

  2003cited by this paper
• Macrophage cholesterol transport: a critical player in foam cell formation

  2003cited by this paper
• Soluble CD40 ligand in acute coronary syndromes.

  2003cited by this paper
• Inflammation in atherosclerosis

  2002influential reference
• Highly effective reduction of C-reactive protein in patients with coronary heart disease by extracorporeal low density lipoprotein apheresis.

  2002cited by this paper
• Inflammation and Atherosclerosis

  2002cited by this paper
• Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.

  2002cited by this paper
• Progression of Atheroma: A Struggle Between Death and Procreation

  2002cited by this paper
• CD40-CD40L interactions in atherosclerosis.

  2002cited by this paper
• AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• C-reactive protein and other markers of inflammation among patients undergoing HELP LDL apheresis.

  2001cited by this paper
• CD40 Signaling and Plaque Instability

  2001cited by this paper
• The relationship of soluble ICAM-1, VCAM-1, P-selectin and E-selectin to cardiovascular disease risk factors in healthy men and women

  2001cited by this paper
• Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.

  2001influential reference
• Consistent lowering of clotting factors for the treatment of acute cardiovascular syndromes and hypercoagulability: a different pathophysiological approach.

  2001cited by this paper
• Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy.

  2001cited by this paper
• NF-κB: pivotal mediator or innocent bystander in atherogenesis?

  2001cited by this paper
• Genetic predisposition to coronary artery disease.

  2001cited by this paper
• Expression of class A scavenger receptor inhibits apoptosis of macrophages triggered by oxidized low density lipoprotein and oxysterol.

  2000cited by this paper
• Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering

  2000cited by this paper
• The Transcription Factor NF-κB and the Regulation of Vascular Cell Function

  2000cited by this paper
• De novo expression of the class-A macrophage scavenger receptor conferring resistance to apoptosis in differentiated human THP-1 monocytic cells

  1999cited by this paper
• Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes.

  1999cited by this paper
• Scavenger receptor activity is increased in macrophages from rabbits with low atherosclerotic response: studies in normocholesterolemic high and low atherosclerotic response rabbits.

  1999cited by this paper
• Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype.

  1999cited by this paper
• Requirement for CD154 in the progression of atherosclerosis

  1999cited by this paper
• Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization?

  1999cited by this paper
• Nuclear factor k B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy

  1998cited by this paper
• Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions.

  1998cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• Fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes.

  1998cited by this paper
• Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis

  1998cited by this paper
• CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

  1998cited by this paper
• Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.

  1998cited by this paper
• Reduction of atherosclerosis in mice by inhibition of CD40 signalling

  1998cited by this paper
• Dysregulation of Monocytic Nuclear Factor-κB by Oxidized Low-Density Lipoprotein

  1997cited by this paper
• Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

  1997cited by this paper
• Role of nuclear factor‐kappa B in atherogenesis

  1997cited by this paper
• AP-1 function and regulation.

  1997cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Study of causes underlying the low atherosclerotic response to dietary hypercholesterolemia in a selected strain of rabbits.

  1996cited by this paper
• Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.

  1995cited by this paper
• Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation.

  1995cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia

  1995cited by this paper
• An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium.

  1993cited by this paper
• Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages.

  1993cited by this paper
• Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway.

  1993cited by this paper
• Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis.

  1991cited by this paper
• Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterol.

  1984cited by this paper
• Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase.

  1980cited by this paper
• The pathogenesis of atherosclerosis (first of two parts).

  1976cited by this paper
• The pathogenesis of atherosclerosis (second of two parts).

  1976cited by this paper
• ANGINA PECTORIS IN HEREDITARY XANTHOMATOSIS

  1939cited by this paper
• Über den Gehalt normaler und atheromatöser Aorten an Cholesterin und Cholesterinestern.

  year unknowncited by this paper

• Modifiable contributing factors to COVID-19: A comprehensive review

  2022cites this paper
• Stoffwechselerkrankungen

  2020cites this paper